Home/Filings/4/A/0001628280-24-052517
4/A//SEC Filing

Stelmakh Edward 4/A

Accession 0001628280-24-052517

CIK 0001448431other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 4:38 PM ET

Size

5.2 KB

Accession

0001628280-24-052517

Insider Transaction Report

Form 4/AAmended
Period: 2024-02-15
Transactions
  • Award

    Common Stock

    2024-02-15+033,365 total
Footnotes (1)
  • [F1]On April 24, 2024, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently understated in column 5 the number of shares directly owned by the reporting person following the reported transaction. This inadvertent understatement has been corrected in this amended filing. This understatement also affected the holdings reported in subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001887046

Filing Metadata

Form type
4/A
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:38 PM ET
Size
5.2 KB